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To the Editor
Asthma management is a daily challenge in 
pediatric practice as many clinical and functional 
aspects continuously change over time. Asthma 
management should be oriented to attain and 
maintain asthma control [1]. The asthma control 
level drives the intensity of care. Different tools 
can measure asthma control. The Global Initiative 
for Asthma (GINA) classification and the Asthma 
Control Test (ACT), and its pediatric version 
(childhood-ACT, C-ACT) are the most commonly 
used in clinical practice [1–3]. These two ways are 
popular in daily practice. Other instruments also 
are available, including the Composite Asthma 
Severity Index (CASI), which measures asthma 
severity [4]. Asthma severity is another facet 
relevant in the management. However, asthma 
control and severity are closely connected, and 
the concept of control/severity practically com-
bines the two measures.
In this regard, Mokhallati et al. [5] evalu-
ated the predictive value of CASI in a cohort of 
108 children with asthma. ACT and C-ACT were 
also used to obtain additional information for con-
textualizing CASI. This study showed that CASI 
actually predicted the physician assessments 
of asthma control and severity and confirmed 
that both were not distinct entities. Moreover, 
ACT/C-ACT was a reliable predictor of physi-
cian-assessed control. Based on this background, 
we would evaluate the role of ACT/C-ACT in 
a large multicenter nationwide study. For this 
purpose, the Italian Society of Paediatric Allergy 
and Immunology promoted a perspectival study 
(“ControL’Asma”) to investigate asthma control 
in children and adolescents managed in clinical 
practice. The first outcomes showed that the type 
2 high allergic phenotype was prevalent, and 
partly controlled-uncontrolled asthma affected 
about half of the participants [6]. Further, the 
project also demonstrated that rhinitis is frequent 
asthma comorbidity and rhinitis phenotyping is 
useful for adequately managing asthma [7].
Consequently, the present study aimed to 
thoroughly evaluate the asthma control assess-
ment in 469 children and adolescents (69.3% 
males, mean age 11.2 years) consecutively visited 
across 10 Italian Paediatric Allergy centers. All 
patients were currently treated according to the 
GINA guidelines based on the asthma control 
level. The methodology has been reported in 
detail elsewhere [6]. 
The Ethics Committee of the Istituto Gianni-
na Gaslini of Genoa initially approved the proce-
dure (code number: 22253/2017; in the context 
of the Italian Project “ControL’Asma” promoted 
by the Italian Society of Paediatric Allergy and 
Immunology). All the other Review Ethics Com-
mittees further approved the study procedure 
and written informed consent was obtained from 
all parents. Clinical data were recorded by an 
electronic case report form designed expressly 
for this study.
Patient’s characteristics at baseline were 
described as mean with standard deviation (SD), 
median with interquartile ranges (IQR), or count 
and percentage (%), as appropriate. Univariable 
and multivariate logistic regression models were 
performed to evaluate factors associated with 
uncontrolled asthma. Variables with p < 0.20 in 
the univariate analysis were candidates for sub-
sequent multivariate analysis. Receiver operating 
characteristic curve analysis was graphed to 
calculate the Area Under the Curve (AUC) and 
identify the optimal cut-off score for ACT to 
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discriminate uncontrolled from controlled asth-
ma (by calculating Youden’s index). Two-sided 
P-values ≤ 0.05 were considered statistically
significant. The analyses were computed using
SPSS Statistics version 21.0 (IBM Corp., Armonk,
NY, USA).
Ac c o r d i n g  t o  G I N A  c l a s s i f i c a t i o n , 
261 (55.6%) subjects had well-controlled asth-
ma, 152 (32.4%) partly-controlled, and 56 (12%) 
uncontrolled. At the multivariate analysis, only 
the adjusted age C-ACT/ACT (OR [odds ratio] 
= 0.66; CI [confidence interval] 0.59–0.75; p 
< 0.001) and forced volume vital capacity (OR 
= 0.95; CI 0.91–0.98; p = 0.002) were signifi-
cantly associated with uncontrolled asthma. In 
particular, subjects with uncontrolled asthma 
had a C-ACT/ACT score of 17 (IQR 13–18), sig-
nificantly (p < 0.001) lower than subjects with 
controlled/partly-controlled asthma (23; IQR 
20–25). The receiver operating characteristic 
curve identified a value of 18.5 as a reliable 
cut-off with AUC 0.875 (CI 0.83–0.91; p < 
0.001), 87% sensitivity, 78.6% specificity, and 
0.66 Youden Index, as reported in the Figure 1.
These outcomes are consistent with previous 
studies that provided robust evidence for the ACT 
as a reliable questionnaire to assess asthma con-
trol. In particular, an 18-month follow-up study 
demonstrated that C-ACT use improved asthma 
care [8]. Moreover, the ATS/ERS Task Force on 
asthma control concluded that the assessment 
should be multicomponent and consider clinical 
aspects using adequate tools, including the ACT 
[9]. A systematic review exploring the diagnostic 
performance of asthma control questionnaires 
concluded that ACT had low accuracy in iden-
tifying patients with uncontrolled asthma as the 
AUC was 0.69 [10]. Our outcomes were incon-
sistent with these findings. Namely, the ACT 
performance was good to define uncontrolled 
asthma correctly.
ACT is, therefore, a reliable and practical tool 
to precisely assess asthma control. Other tools, 
including CASI and asthma control questionnaire, 
need the lung function measurement. It yields the 
tests unusable in primary care settings, where 
spirometry is frequently unavailable. Moreover, 
in the COVID-19 pandemic era, telemedicine 
represents a promising alternative to office vis-
its. Thus, careful history and ACT could repre-
sent an optimal way to manage asthma at home 
realistically. 
On the other hand, the current study had 
some limitations, including the cross-sectional 
design and the lack of biomarker evaluation. 
However, the study was conducted in a real-world 
setting, the number of participants was large, and 
the nationwide distribution of centers across Italy. 
These factors contributed to give outcomes that 
reflect what occurs in daily pediatric practice.
In conclusion, the ControL’Asma study 
showed that ACT is a suitable tool for identify-
ing children and adolescents with uncontrolled 
asthma. As it is a questionnaire, ACT could be 
used in every setting, including primary care 
clinic and at home.
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